Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

First Trust NYSE Arca Biotechnology Index Fund

+ Add to Watchlist

FBT:US

115.0599 USD 0.9001 0.78%

As of 10:08:37 ET on 03/03/2015.

Snapshot for First Trust NYSE Arca Biotechnology Index Fund (FBT)

Open: 115.6700 High - Low: 115.9343 - 114.3400 Primary Exchange: NYSE Arca
Volume: 28,893 52-Week Range: 67.2700 - 117.0950 Beta vs BTK: 0.9994

ETF Chart for FBT

No chart data available.
  • FBT:US 115.0000
  • 1D
  • 1M
  • 1Y
115.9600
Interactive FBT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBT

First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of an equity index called the Amex Biotechnology Index.

Inception Date: 2006-06-23 Telephone: 1-630-765-8000
Managers: -
Web Site: www.ftportfolios.com

Fundamentals for FBT

NAV (on 2015-03-02) 115.9110
Assets (M) (on 2015-03-02) 2,909.3670
Shares out (M) 25.10
Market Cap (M) 2,910.60
% Premium 0.04
Average 52-Week % Premium 0.0290
Fund Leveraged N

Dividends for FBT

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-23) 0.0524
Dividend Yield (ttm) 0.05%

Performance for FBT

1-Month +6.25% 1-Year +39.05%
3-Month +13.38% 3-Year +42.98%
Year To Date +13.66% 5-Year +27.75%
Expense Ratio 0.60

Top Fund Holdings for FBT

Filing Date: 03/02/2015
Name Position Value % of Total
Pharmacyclics Inc 617,427 136,630,421 4.696%
Intercept Pharmaceuticals Inc 596,659 134,570,471 4.625%
Celldex Therapeutics Inc 4,428,208 120,137,283 4.129%
Novavax Inc 13,197,488 117,721,593 4.046%
Incyte Corp 1,208,875 107,203,035 3.685%
Biogen Idec Inc 254,654 105,882,587 3.639%
Seattle Genetics Inc 2,864,619 103,126,284 3.544%
Charles River Laboratories Int 1,317,934 101,151,435 3.477%
Medivation Inc 828,433 100,281,815 3.447%
United Therapeutics Corp 637,168 99,028,651 3.404%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil